Epizyme, Inc.

Tower Research Capital LLC (TRC)

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

12,427

Value ($000)

19

Weight

0.0%

2013 Q4 - 2022 Q2 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	19	0.0%	12,427	6/30/2022
2022 Q1	5/12/2022	30	0.0%	26,095	3/31/2022
2021 Q4	2/14/2022	72	0.0%	28,603	12/31/2021
2021 Q3	11/15/2021	85	0.0%	16,607	9/30/2021
2021 Q2	8/16/2021	72	0.0%	8,671	6/30/2021
2021 Q1	5/17/2021	461	0.0%	52,934	3/31/2021
2020 Q4	2/16/2021	157	0.0%	14,447	12/31/2020
2020 Q3	11/16/2020	65	0.0%	5,424	9/30/2020
2020 Q2	8/13/2020	278	0.0%	17,321	6/30/2020
2019 Q4	2/7/2020	42	0.0%	1,706	12/31/2019
2014 Q1	5/2/2014	41	0.0%	1,800	3/31/2014
2013 Q4	1/31/2014	22	0.0%	1,042	12/31/2013